C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
12/2007
12/20/2007	US20070293503 Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists
12/19/2007	EP1866298A2 Hydroxysteroid dehydrogenase inhibitors
12/19/2007	EP1711480B1 Novel long-working beta-2-agonists and use thereof as medicaments
12/19/2007	EP1032556B1 Pharmaceutically active compounds and methods of use
12/19/2007	CN100355824C Ultraviolet radiation absorbents for thermoplastic polymers and methods of producing same
12/18/2007	US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
12/18/2007	CA2489763C Pharmaceutical salts of reboxetine
12/18/2007	CA2268077C 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof
12/13/2007	WO2006079720A8 Novel heterocyclic oxime derivatives, method for preparing same and use thereof as hypoglycaemic or hypolipidemic agents
12/13/2007	US20070287843 Methods and Intermediates for the Synthesis of Delta-9 Tetrahydrocannabinol
12/13/2007	US20070287710 Piperidinediyl-containing sulfonamide; NPY Y5 receptor antagonist activity; antiobesity agent or anorectic agent
12/13/2007	US20070287706 Certain substituted quinolones, compositions, and uses thereof
12/12/2007	CN101087773A Inhibitors of c-fms kinase
12/12/2007	CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
12/12/2007	CN100354270C Photochromic oxazine compounds and methods for their manufacture
12/11/2007	US7307076 Beta agonists for the treatment of respiratory diseases
12/11/2007	US7307075 Tetrahydroquinoline analogues as muscarinic agonists
12/06/2007	WO2007139002A1 Method for producing nitrogen-containing fused ring compound
12/06/2007	WO2007138998A1 Pharmaceutical composition comprising nitrogenated fused cyclic compound
12/06/2007	WO2007117560A3 Piperidine and morpholine renin inhibitors
12/06/2007	US20070282100 Boronic ester and acid compounds, synthesis and uses
12/06/2007	US20070281930 bicyclic bisamides for controlling acarina
12/04/2007	US7304155 Nonsteroid; enantiomers are selective antagonists of the estrogen beta receptor relative to the alpha receptor; tissue selectivity; fewer estrogen-related side effects; menopause, osteoporosis, hormone replacent therapy, contraceptive, endometriosis; 10-aminoalkyloxyphenyl benzo[b]fluorene 2,8-diols
11/2007
11/29/2007	WO2007117559A3 Renin inhibitors
11/29/2007	WO2007117557A3 Diaminopropanol renin inhibitors
11/29/2007	US20070276138 Modulators of peroxisome proliferator activated receptors
11/29/2007	US20070275956 Novel Heterocyclic Compounds
11/29/2007	US20070274933 Amino- and hydroxysubstituted triphenyl-S-triazines as stabilizers
11/29/2007	CA2651732A1 Intracellular kinase inhibitors
11/28/2007	EP1858327A1 Use of 4-aminopyrimidines for the prevention of fungal pests novel 4-aminopyrimidines method for production thereof and agents comprising the same
11/28/2007	CN101080384A Manufacture process of N-substituted salicylamide
11/27/2007	US7301028 Mitotic kinesin inhibitors
11/22/2007	WO2007133800A2 Toll-like receptor (tlr) stimulation for ocular angiogenesis and macular degeneration
11/22/2007	WO2007117482A3 Renin inhibitors
11/22/2007	US20070270418 Inhibitors of P38 and Methods of Using the Same
11/22/2007	CA2651817A1 3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as cetp inhibitors
11/21/2007	EP1856070A1 Novel drugs for treating respiratory diseases
11/21/2007	EP1856063A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
11/21/2007	EP1663982B1 Aminoquinoline derivatives and their use as adenosine a3 ligands
11/21/2007	EP1056728B1 Dihydro-benzo(1,4)oxazines and tetrahydroquinoxalines
11/21/2007	CN101074242A Cells accumulation for sphosphonate analogs of HIV protease inhibitor compound and the same compound
11/20/2007	US7297819 Open-chain alkoxyamines and their corresponding nitroxides for controlled low temperature radical polymerization
11/20/2007	US7297696 Antiarthritic agents; antihistamines; atherosclerosis; multiple sclerosis; Crohn's disease; nephritis; pancreastitis; skin disorders; restenosis; prevent leukocyte migration
11/15/2007	WO2007099048A3 Use of polynuclear phenolic compounds as stabilisers
11/15/2007	WO2007091009A3 Preparation of delmopinol
11/15/2007	US20070265268 inhibiting heat shock protein 90 (Hsp90) family protein comprising administering benzoic acid derivatives or prodrugs, for the treatment of breast cancer or leukemia
11/15/2007	US20070265257 Morpholine Compound
11/15/2007	US20070265252 modulator of cholesteryl ester transfer protein (CETP), such as 1,1,1-Trifluoro-3-[3-[3-(1,1,2,2-tetrafluoro-ethoxy)-phenyl]-8-(3-trifluoromethoxy-phenyl)-2,3-dihydro-benzo[1,4]oxazin-4-yl]-propan-2-ol, used for treating cardiovascular disorders, dyslipidemia, and metabolic disorders
11/15/2007	US20070265165 Novel herbicides
11/15/2007	US20070264217 3-(2-hydroxyphenyl)-2-propenamides that react to form a lactone and an amine; laundry detergents, perfumes, shampoos and hair conditioners
11/14/2007	EP1853610A1 N-phenyl benzamide derivatives as sirtuin modulators
11/14/2007	EP1853572A1 Fluorinated phno and analogs thereof
11/14/2007	EP1509537B9 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/14/2007	CN101072765A Phenylpiperazines with a combination of affinity for dopamine -D2 receptors and serotonin reuptake sites
11/14/2007	CN101070309A Substituted piperazines (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
11/13/2007	US7294637 Such as [1-(4-chloro-phenyl)-cyclobutyl]-(3-hydroxymethyl piperidin-1-yl)-methadone for treating cocaine and/or methamphetamine addiction
11/13/2007	US7294623 Benzyl morpholine derivatives
11/08/2007	WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007	WO2007125398A2 : sulfonamide compounds as antagonists of the n-type calcium channel
11/08/2007	US20070259871 Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90
11/08/2007	CA2650683A1 Amine derivative having npy y5 receptor antagonist activity
11/07/2007	EP1852427A1 Biologically active 4H-Benzo [1,4] oxazin-3-ones
11/07/2007	EP1852119A1 Pharmaceutical composition containing phenoxazinium compound as active ingredient
11/07/2007	EP1851199A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
11/07/2007	CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007	CN100347151C Novel aminobenzoephenones
11/06/2007	US7291644 For therapy and prophylaxis of allergic disorder, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, pleuritis complicated by rheumatoid arthritis, cerebrovascular disease
11/06/2007	US7291615 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents
11/06/2007	CA2263927C Heterocyclic thioesters and ketones
11/06/2007	CA2241666C Tricyclic compounds, their production and use
11/01/2007	WO2007123516A1 C-fms kinase inhibitors
11/01/2007	WO2007122277A1 4-acyloyloxy-2h-1,4-benzoxazin-3-(4h)one derivatives with phytotoxic activity
11/01/2007	WO2007057768A3 Sulfonyl derivatives
11/01/2007	US20070255057 Mono-nitration of aromatic compounds via nitrate salts
11/01/2007	US20070254875 Androgen Receptor Modulator Compounds and Methods
11/01/2007	US20070254874 gastrointestinal disorders, urinary tract disorders such as hyperactive bladder, and cardiovascular disorders without side effects related to CNS activity; acid moiety makes drug unable to cross the blood-brain barrier; carboxy, phosphonic, sulfonic, or phosphoric acid derivative of piboserod (DDL-6001)
11/01/2007	US20070254873 Chemical Compounds
11/01/2007	US20070254872 Antibacterial Agents
11/01/2007	US20070254866 Aminoquinolones as GSK-3 inhibitors
11/01/2007	CA2649512A1 C-fms kinase inhibitors
10/2007
10/31/2007	EP1848686A2 9-substituted tetracyclines
10/31/2007	EP1687638B1 Analysis of mass spectral data in the quiet zones
10/31/2007	CN101065367A Aryl-ureido benzoxazinone compounds
10/30/2007	US7288538 Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists
10/30/2007	CA2264002C Naphthyl compounds, intermediates, compositions, and methods of use
10/25/2007	US20070249605 such as methyl 2-(4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetate
10/23/2007	US7285568 Substituted p-(2-alkoxy-2-acylethyl)biphenyl compounds, e.g., 1-[4'-(2-ethoxy-3-morpholin-4-yl-3-oxopropyl)biphenyl-3-yl]-3-heptyl-1-methylurea; useful in human or veterinary medicine: dermatology, cardiovascular diseases, immune diseases, and diseases associated with lipid metabolism
10/18/2007	WO2007117560A2 Piperidine and morpholine renin inhibitors
10/18/2007	WO2007117559A2 Renin inhibitors
10/18/2007	WO2007117557A2 Diaminopropanol renin inhibitors
10/18/2007	WO2007117482A2 Renin inhibitors
10/18/2007	US20070244122 Derivatives of sulindac, use thereof and preparation thereof
10/17/2007	EP1844029A1 Novel heterocyclic oxime derivatives, method for preparing same and use thereof as hypoglycaemic or hypolipidemic agents
10/17/2007	EP1844026A2 Morpholines as 5ht2c agonists
10/17/2007	EP1284724A4 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
10/17/2007	CN101056845A Substituted aniline derivatives
10/17/2007	CN100343285C Heterocyclic alkoxyl amine as regulator in controlled free radical polymerization method
10/11/2007	WO2007114213A1 Substituted bicyclic cyclic derivative and use thereof
10/11/2007	WO2007113218A1 Process for producing 3-[4-(1,1-dimethyl-propyl)-phenyl]-2-methyl-propionaldehyde and cis-4-{3-[4-(1,1-dimethyl-propyl)-phenyl]-2-methyl-propyl}-2,6-dimethyl-morpholine (amorolfine)
10/11/2007	WO2000072801A3 Alpha v integrin receptor antagonists

1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 112